A study of major US private payers showed an important role and considerable shortcomings of external health technology assessment in coverage decisions on personalized medicine. We reviewed 7 HTA ...

Novel medicines hold promise for patients, but rising costs pose affordability and equity challenges for health systems ...

Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative treatments to market more quickly. However, they also require developers to ...

This article is part of a Health Affairs Forefront short series, “Enhancing Value By Evaluating Health Care Services.” The series discusses ways to extend the use of tools for clinical and economic ...

A white paper published by the Institute for Clinical and Economic Review (ICER) established a series of recommendations and guidelines for health technology assessment that aim to address health care ...

A young female hospital patient lies in bed while attached to a medical transfusion device in a London medical clinic. Health technology assessment (HTA) entities adopt different value frameworks as a ...

HTA assessments highlight importance of timely and equitable access to QALSODY for this ultra-rare genetic form of ALS and urgent need for therapies that slow progression, preserve function and ...

This post is part of the Health Affairs Forefront short series, “Value Assessment: Where Do We Go Post-COVID?” The series explores what we have learned about value assessment and related issues during ...

The Ministry of Public Health (MoPH) highlighted its commitment to strengthening national capabilities in Health Technology Assessment (HTA) and health policy, having established a dedicated national ...

Health technology assessment (HTA) plays an increasing role in translating emerging technologies into clinical practice and policy. Private payers are important users of HTA whose decisions impact ...

Health technology assessment (HTA) plays an increasing role in translating emerging technologies into clinical practice and policy. Private payers are important users of HTA whose decisions impact ...